How will your company convince payers that they should pay for that new health innovation you’ve been developing for years? Do you have the data to prove your drug or device is worth the price you plan to charge? If you don’t, do you at least have a plan to get the bulletproof evidence it will take to persuade the payers?
These questions might have seemed irrelevant to entrepreneurs five years ago, when winning FDA approval was the name of the game. But they are front-burner strategic issues now for all life sciences companies as payers are clamping down on runaway healthcare spending. And we’re putting these questions out there for the Seattle biotech community agenda at our next big event—“Biotech in the Belt-Tightening Era” on April 9.
We’re now just two weeks away from the big event, and today is the last day to snap up tickets at the discounted “saver” rate. What you’ll hear at this event are not a bunch of rambling, unfocused talks. You will hear a series of engaging, 1-on-1 interviews with West Coast biotech thinkers and doers, who will talk about how they’ve adapted their businesses to compete in this new era.
Here’s how you can expect the afternoon to flow:
1 pm. Registration/Networking
2 pm. Welcoming remarks. Northeastern University and Xconomy
2:05 pm. Scott Ramsey, Fred Hutchinson Cancer Research Center.
2:35 pm. Mitch Gold, Alpine Biosciences
2:55 pm. Clay Siegall, Seattle Genetics
3:15 pm. Chad Robins, Adaptive Biotechnologies
3:35 pm Networking break
4:05 pm. Mark Litton, Alder Biopharmaceuticals
4:25 pm. Al Luderer, Integrated Diagnostics
4:45 pm. Kim Popovits, Genomic Health
5:05 pm Risa Stack, GE healthymagination & Robert Nelsen, Arch Venture Partners
5:30 pm Networking reception
6:30 pm End
This is one of just two major public life sciences events that we are planning this year at Xconomy Seattle, and it represents of the best networking opportunities of the year for the Seattle biotech industry. More than 125 people have registered so far. I look forward to seeing lots of readers there on April 9.
